Don't Ignore The Insider Selling In ICU Medical
Don't Ignore The Insider Selling In ICU Medical
Anyone interested in ICU Medical, Inc. (NASDAQ:ICUI) should probably be aware that a company insider, Daniel Woolson, recently divested US$408k worth of shares in the company, at an average price of US$163 each. That sale was 16% of their holding, so it does make us raise an eyebrow.
對於ICU醫療股票（納斯達克股票代碼：ICUI）感興趣的人，應該注意到公司內部人員丹尼爾·沃爾森最近以每股163美元的平均價值脫售了價值40.8萬美元的股票。這筆交易佔他們持股的16%，這確實讓我們感到警惕。
The Last 12 Months Of Insider Transactions At ICU Medical
在過去12個月，ICU醫療公司內部交易情況
Over the last year, we can see that the biggest insider sale was by the insider, George Lopez, for US$4.4m worth of shares, at about US$107 per share. So it's clear an insider wanted to take some cash off the table, even below the current price of US$165. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. It is worth noting that this sale was only 3.3% of George Lopez's holding.
在過去一年中，我們可以看到最大的內部銷售是由內部人員喬治·洛佩茲以每股107美元的價格出售了價值440萬美元的股票。所以很明顯，內部人員希望獲得一些現金回報，甚至低於當前165美元的價格。一般來說，當內部人員以低於當前價位出售股票時，我們會認爲這是令人沮喪的，因爲這暗示他們對較低的估值感到滿意。不過請注意，賣方出售可能有各種原因，所以我們不能確定他們對股票價格持何種看法。值得注意的是，此次出售僅佔喬治·洛佩茲持股的3.3%。
In the last year ICU Medical insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
對於普通股東來說，值得檢查公司內部人員持有的股份數量。通常，持股超過的內部人員比其他人更有可能被激勵爲長期發展公司。icu醫療公司的內部人員擁有價值約1.69億美元的股份（佔公司總股本的6.0％）。我喜歡看到這種程度的內部人員持股，因爲它增加了管理層考慮股東最佳利益的機會。
I will like ICU Medical better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
如果我看到一些大內部人買入，我會更喜歡icu醫療。在我們等待的時候，看看這份免費的被低估和小盤股股票名單，其中有相當多的近期內部人買入。
Does ICU Medical Boast High Insider Ownership?
icu醫療是否擁有高內部人持股？
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. ICU Medical insiders own about US$240m worth of shares (which is 5.9% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
許多投資者喜歡檢查公司被內部人擁有多少。高內部人持股往往會使公司管理層更加關注股東利益。icu醫療的內部人持有大約2.4億美元的股份（佔公司總股本的5.9%）。這種由內部人持有的重要股權一般會增加公司以所有股東利益爲導向的可能性。
What Might The Insider Transactions At ICU Medical Tell Us?
icu醫療公司的內部交易可能告訴我們什麼？內部人員最近拋售股票，但他們並沒有購買。過去一年中，也沒有購買任何股票。看到高內部人員持股是好事，但內部人員的出售讓我們感到謹慎。除了了解正在進行的內部交易，識別icu醫療公司面臨的風險也是有益的。事實上，我們發現了icu醫療公司的兩個警告信號，您應該注意其中1個警告信號有點令人擔憂。
An insider sold ICU Medical shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing ICU Medical. Every company has risks, and we've spotted 2 warning signs for ICU Medical (of which 1 doesn't sit too well with us!) you should know about.
最近有一位內部人賣出了icu醫療的股票，但他們沒有買入任何股票。在過去的一年裏，也沒有任何購買讓我們感到放心的情況。雖然內部人在公司擁有很多股份（這是好事），但我們對他們的交易分析並沒有讓我們對該公司感到有信心。除了了解正在進行的內部交易，還有助於識別icu醫療面臨的風險。每家公司都有風險，我們發現了2個警示信號對icu醫療不太好，你應該知道。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
當然，您可能會在其他地方找到一項出色的投資。因此，請查看此免費的有趣公司列表。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言，內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置，但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋？對內容有任何疑慮？請直接與我們聯繫。或者，發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。